Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Blood|September 23, 2022
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphomaKoji Izutsu, Shinichi Makita, Kisato Nosaka, et al.
Blood Advances|October 22, 2020
Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational studyKentaro Yonekura, Shigeru Kusumoto, Ilseung Choi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 10, 2025
Letermovir prophylaxis and risk of bacterial or fungal infection after allogeneic hematopoietic cell transplantationShun-Ichi Kimura, Shunto Kawamura, Takashi Toya, et al.
Haematologica|April 14, 2022
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphomaNorio Tanaka, Seiichi Mori, Kazuma Kiyotani, et al.
Hematological Oncology|July 14, 2026
Application Timing-Dependent Impact of Donor Source on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/LymphomaHidehiro Itonaga, Takuya Fukushima, Hiroyuki Muranushi, et al.
Blood Advances|December 22, 2025
Integrated Genetic Analyses Identified T-cell Neoplasms Other Than Adult T-cell Leukemia/Lymphoma in HTLV-1 CarriersYu Naito, Takahiko Yasuda, Shugo Sakihama, et al.
British Journal of Haematology|June 16, 2026
Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experienceHidehiro Itonaga, Takuya Fukushima, Koji Kato, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 8, 2025
Prognostic Impact of Cytomegalovirus Reactivation After Transplantation From Cord Blood Compared to Other Donor Sources in Patients With Adult T-Cell Leukemia/Lymphoma in the Pre-Letermovir EraTakuya Fukushima, Hidehiro Itonaga, Hikaru Sakamoto, et al.
American Journal of Hematology|May 23, 2025
Impact of Conditioning Intensity on Clinical Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Relapse After First TransplantationKazuki Yoshimura, Hideki Nakasone, Masaharu Tamaki, et al.
Annals of Hematology|November 19, 2024
Reappraising the prognostic relevance of cytogenetic risk in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationShohei Mizuno, Hiroki Hosoi, Akiyoshi Takami, et al.
Pageof 14